| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pacemaker, Artificial | 25 | 2011 | 157 | 1.800 |
Why?
|
| Defibrillators, Implantable | 6 | 2011 | 329 | 0.840 |
Why?
|
| Heart Valve Prosthesis | 12 | 2018 | 222 | 0.680 |
Why?
|
| Device Removal | 3 | 2010 | 100 | 0.650 |
Why?
|
| Electrodes, Implanted | 6 | 2011 | 98 | 0.600 |
Why?
|
| Coronary Artery Bypass | 11 | 2011 | 218 | 0.460 |
Why?
|
| Heart Valve Prosthesis Implantation | 5 | 2018 | 164 | 0.420 |
Why?
|
| Cardiac Pacing, Artificial | 9 | 1993 | 174 | 0.400 |
Why?
|
| Dermis | 1 | 2011 | 29 | 0.380 |
Why?
|
| Aortic Valve | 9 | 2018 | 249 | 0.380 |
Why?
|
| Skin Transplantation | 1 | 2011 | 45 | 0.370 |
Why?
|
| Prosthesis-Related Infections | 1 | 2011 | 70 | 0.360 |
Why?
|
| Thoracic Surgery | 2 | 2007 | 72 | 0.360 |
Why?
|
| Heart Block | 9 | 1994 | 49 | 0.310 |
Why?
|
| Mitral Valve | 9 | 2018 | 166 | 0.310 |
Why?
|
| Drug Dosage Calculations | 1 | 2007 | 9 | 0.310 |
Why?
|
| Coronary Care Units | 1 | 2007 | 12 | 0.310 |
Why?
|
| Databases as Topic | 1 | 2007 | 49 | 0.290 |
Why?
|
| Disclosure | 1 | 2007 | 45 | 0.290 |
Why?
|
| Insurance, Health | 1 | 2007 | 200 | 0.260 |
Why?
|
| Cardiac Surgical Procedures | 6 | 2012 | 450 | 0.260 |
Why?
|
| Cardiopulmonary Bypass | 8 | 2012 | 250 | 0.250 |
Why?
|
| Aged | 40 | 2018 | 14842 | 0.250 |
Why?
|
| Hypoglycemic Agents | 1 | 2007 | 361 | 0.250 |
Why?
|
| Insulin | 1 | 2007 | 617 | 0.240 |
Why?
|
| Blood Glucose | 1 | 2007 | 631 | 0.240 |
Why?
|
| Middle Aged | 51 | 2018 | 21119 | 0.240 |
Why?
|
| Hospitals, University | 5 | 2011 | 169 | 0.220 |
Why?
|
| Humans | 81 | 2018 | 68549 | 0.220 |
Why?
|
| Postoperative Complications | 13 | 2018 | 1615 | 0.220 |
Why?
|
| Male | 58 | 2018 | 37283 | 0.210 |
Why?
|
| Esophageal Neoplasms | 4 | 1991 | 150 | 0.200 |
Why?
|
| Aged, 80 and over | 13 | 2018 | 4843 | 0.190 |
Why?
|
| Female | 52 | 2018 | 38021 | 0.180 |
Why?
|
| Aortic Valve Stenosis | 2 | 2011 | 177 | 0.180 |
Why?
|
| Aorta, Thoracic | 2 | 2012 | 211 | 0.180 |
Why?
|
| Sick Sinus Syndrome | 5 | 2005 | 18 | 0.170 |
Why?
|
| Heart Transplantation | 4 | 2008 | 328 | 0.160 |
Why?
|
| Adolescent | 20 | 2018 | 8904 | 0.160 |
Why?
|
| Equipment Design | 7 | 2008 | 500 | 0.160 |
Why?
|
| Palliative Care | 2 | 1991 | 271 | 0.150 |
Why?
|
| Retrospective Studies | 18 | 2011 | 7268 | 0.150 |
Why?
|
| Adult | 33 | 2018 | 21379 | 0.150 |
Why?
|
| Child, Preschool | 11 | 2011 | 3187 | 0.150 |
Why?
|
| Follow-Up Studies | 14 | 2011 | 3256 | 0.150 |
Why?
|
| Arrhythmias, Cardiac | 4 | 1993 | 239 | 0.140 |
Why?
|
| Midazolam | 1 | 1996 | 46 | 0.140 |
Why?
|
| Electrocardiography | 8 | 1995 | 601 | 0.140 |
Why?
|
| Equipment Failure | 7 | 2008 | 112 | 0.140 |
Why?
|
| Postoperative Hemorrhage | 3 | 2011 | 69 | 0.140 |
Why?
|
| Anesthesia, General | 1 | 1996 | 86 | 0.140 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 1991 | 624 | 0.130 |
Why?
|
| Hypnotics and Sedatives | 1 | 1996 | 96 | 0.130 |
Why?
|
| Mitral Valve Insufficiency | 2 | 1993 | 99 | 0.130 |
Why?
|
| Child | 16 | 2011 | 6401 | 0.130 |
Why?
|
| Time Factors | 13 | 2011 | 4655 | 0.120 |
Why?
|
| Treatment Outcome | 7 | 2011 | 7028 | 0.120 |
Why?
|
| Assisted Circulation | 1 | 1994 | 7 | 0.120 |
Why?
|
| Bioprosthesis | 3 | 2010 | 101 | 0.120 |
Why?
|
| Mitral Valve Stenosis | 1 | 1993 | 15 | 0.110 |
Why?
|
| Muscles | 1 | 1994 | 158 | 0.110 |
Why?
|
| Tricuspid Valve Insufficiency | 2 | 1991 | 25 | 0.110 |
Why?
|
| Reoperation | 5 | 2018 | 467 | 0.110 |
Why?
|
| Aortic Valve Insufficiency | 1 | 1993 | 47 | 0.110 |
Why?
|
| Muscle Contraction | 1 | 1994 | 210 | 0.110 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2012 | 186 | 0.110 |
Why?
|
| Survival Analysis | 6 | 2018 | 714 | 0.110 |
Why?
|
| Vasoconstriction | 2 | 2004 | 81 | 0.100 |
Why?
|
| Electric Stimulation Therapy | 1 | 1994 | 147 | 0.100 |
Why?
|
| Endothelins | 2 | 2004 | 57 | 0.100 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2012 | 36 | 0.100 |
Why?
|
| Infant | 11 | 2011 | 2891 | 0.100 |
Why?
|
| Plasma | 1 | 2011 | 58 | 0.100 |
Why?
|
| Tricuspid Valve Stenosis | 1 | 1991 | 1 | 0.100 |
Why?
|
| Writing | 1 | 1991 | 29 | 0.100 |
Why?
|
| Aprotinin | 1 | 2011 | 55 | 0.100 |
Why?
|
| Hemostatics | 1 | 2011 | 47 | 0.100 |
Why?
|
| Erythrocytes | 1 | 2011 | 137 | 0.100 |
Why?
|
| Cell-Free System | 1 | 2011 | 43 | 0.100 |
Why?
|
| Tricuspid Valve | 3 | 1991 | 42 | 0.090 |
Why?
|
| Heart Defects, Congenital | 2 | 1992 | 596 | 0.090 |
Why?
|
| Salvage Therapy | 1 | 2011 | 82 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 201 | 0.090 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 242 | 0.090 |
Why?
|
| Esophagus | 3 | 1989 | 303 | 0.090 |
Why?
|
| Endarterectomy, Carotid | 1 | 2011 | 110 | 0.090 |
Why?
|
| Heart Rate | 7 | 1992 | 568 | 0.090 |
Why?
|
| South Carolina | 8 | 2011 | 2752 | 0.090 |
Why?
|
| Carotid Stenosis | 1 | 2011 | 163 | 0.080 |
Why?
|
| Heart Valve Diseases | 4 | 2010 | 123 | 0.080 |
Why?
|
| Azygos Vein | 1 | 1988 | 2 | 0.080 |
Why?
|
| Intubation | 1 | 1989 | 20 | 0.080 |
Why?
|
| Catheters, Indwelling | 2 | 2008 | 72 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2010 | 163 | 0.080 |
Why?
|
| Prosthesis Design | 4 | 2010 | 301 | 0.080 |
Why?
|
| Vena Cava, Superior | 1 | 1988 | 41 | 0.080 |
Why?
|
| Heart Diseases | 2 | 2008 | 276 | 0.080 |
Why?
|
| Factor VIIa | 1 | 2008 | 25 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 3 | 2006 | 365 | 0.080 |
Why?
|
| Thromboembolism | 3 | 1993 | 91 | 0.080 |
Why?
|
| Catheterization, Central Venous | 1 | 2008 | 89 | 0.070 |
Why?
|
| Cerebellar Neoplasms | 2 | 2004 | 17 | 0.070 |
Why?
|
| Medulloblastoma | 2 | 2004 | 24 | 0.070 |
Why?
|
| Aortic Diseases | 1 | 2008 | 113 | 0.070 |
Why?
|
| Infusions, Intravenous | 1 | 2007 | 334 | 0.070 |
Why?
|
| Risk Factors | 6 | 2018 | 5720 | 0.070 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 1986 | 20 | 0.070 |
Why?
|
| Renal Dialysis | 3 | 2000 | 174 | 0.070 |
Why?
|
| Heart Atria | 3 | 1989 | 206 | 0.070 |
Why?
|
| Renal Replacement Therapy | 1 | 2006 | 40 | 0.070 |
Why?
|
| Transplantation | 1 | 2006 | 23 | 0.070 |
Why?
|
| Medicare | 1 | 1988 | 316 | 0.070 |
Why?
|
| Prospective Studies | 8 | 2010 | 3703 | 0.070 |
Why?
|
| Intraoperative Complications | 2 | 2004 | 129 | 0.060 |
Why?
|
| Atrioventricular Node | 1 | 1985 | 39 | 0.060 |
Why?
|
| Blood Loss, Surgical | 2 | 1997 | 79 | 0.060 |
Why?
|
| Papaverine | 1 | 2004 | 10 | 0.060 |
Why?
|
| Hemodynamics | 3 | 1992 | 705 | 0.060 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2004 | 12 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2011 | 696 | 0.060 |
Why?
|
| Internet | 1 | 2007 | 390 | 0.060 |
Why?
|
| Mammary Arteries | 1 | 2004 | 18 | 0.060 |
Why?
|
| Length of Stay | 5 | 2004 | 780 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2007 | 403 | 0.060 |
Why?
|
| Receptor, trkC | 1 | 2004 | 6 | 0.060 |
Why?
|
| Anaplasia | 1 | 2004 | 7 | 0.060 |
Why?
|
| Heart Conduction System | 1 | 1985 | 119 | 0.060 |
Why?
|
| Heart | 5 | 1995 | 850 | 0.060 |
Why?
|
| Triamcinolone | 1 | 1984 | 11 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 212 | 0.060 |
Why?
|
| Povidone | 1 | 1983 | 12 | 0.060 |
Why?
|
| Povidone-Iodine | 1 | 1983 | 16 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2004 | 90 | 0.060 |
Why?
|
| Vasodilator Agents | 1 | 2004 | 138 | 0.060 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2004 | 134 | 0.060 |
Why?
|
| Atmospheric Pressure | 1 | 1983 | 8 | 0.060 |
Why?
|
| Zebrafish Proteins | 1 | 2004 | 100 | 0.060 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2003 | 15 | 0.060 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2003 | 29 | 0.060 |
Why?
|
| Pericardium | 1 | 1983 | 97 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 791 | 0.050 |
Why?
|
| Telomerase | 1 | 2003 | 85 | 0.050 |
Why?
|
| Survival Rate | 5 | 2004 | 1055 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2004 | 1663 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2010 | 2356 | 0.050 |
Why?
|
| Algorithms | 1 | 2007 | 1195 | 0.050 |
Why?
|
| Ventricular Function, Right | 2 | 1992 | 103 | 0.050 |
Why?
|
| Cardiac Catheterization | 4 | 2012 | 419 | 0.050 |
Why?
|
| Infant, Newborn | 4 | 2000 | 2455 | 0.050 |
Why?
|
| Femoral Artery | 2 | 1997 | 139 | 0.050 |
Why?
|
| Swine | 2 | 1994 | 672 | 0.050 |
Why?
|
| Heart Septum | 1 | 1980 | 84 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2004 | 508 | 0.050 |
Why?
|
| Nifedipine | 1 | 2000 | 40 | 0.050 |
Why?
|
| Diltiazem | 1 | 2000 | 25 | 0.050 |
Why?
|
| Pain | 1 | 1984 | 472 | 0.040 |
Why?
|
| Amlodipine | 1 | 2000 | 31 | 0.040 |
Why?
|
| Coronary Circulation | 1 | 2000 | 136 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 1988 | 1172 | 0.040 |
Why?
|
| Blood Coagulation Tests | 4 | 2008 | 31 | 0.040 |
Why?
|
| Radial Artery | 1 | 2000 | 43 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2000 | 137 | 0.040 |
Why?
|
| Blood Coagulation | 3 | 1997 | 123 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2011 | 2004 | 0.040 |
Why?
|
| Hypothermia, Induced | 1 | 1980 | 93 | 0.040 |
Why?
|
| Heart Valves | 1 | 1980 | 171 | 0.040 |
Why?
|
| Surgical Procedures, Operative | 1 | 1980 | 124 | 0.040 |
Why?
|
| Cardiac Output | 2 | 1991 | 133 | 0.040 |
Why?
|
| Heart Arrest, Induced | 2 | 1992 | 52 | 0.040 |
Why?
|
| Young Adult | 3 | 2018 | 5710 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2011 | 880 | 0.040 |
Why?
|
| Aminocaproic Acid | 1 | 1997 | 12 | 0.040 |
Why?
|
| Resorcinols | 1 | 1997 | 8 | 0.040 |
Why?
|
| Femoral Vein | 1 | 1997 | 15 | 0.040 |
Why?
|
| Gelatin | 1 | 1997 | 14 | 0.040 |
Why?
|
| Glutaral | 1 | 1997 | 41 | 0.040 |
Why?
|
| Tissue Adhesives | 1 | 1997 | 17 | 0.040 |
Why?
|
| Foreign Bodies | 2 | 1990 | 58 | 0.040 |
Why?
|
| Formaldehyde | 1 | 1997 | 48 | 0.040 |
Why?
|
| Tranexamic Acid | 1 | 1997 | 37 | 0.040 |
Why?
|
| Antifibrinolytic Agents | 1 | 1997 | 52 | 0.040 |
Why?
|
| Acute Kidney Injury | 2 | 2011 | 232 | 0.040 |
Why?
|
| Blood Transfusion, Autologous | 2 | 1993 | 17 | 0.040 |
Why?
|
| Myocardial Infarction | 2 | 2011 | 807 | 0.040 |
Why?
|
| Fentanyl | 1 | 1996 | 26 | 0.030 |
Why?
|
| Echocardiography | 3 | 2011 | 515 | 0.030 |
Why?
|
| Stroke Volume | 5 | 1992 | 586 | 0.030 |
Why?
|
| Exercise | 2 | 1992 | 658 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 1851 | 0.030 |
Why?
|
| Ventricular Fibrillation | 2 | 1993 | 85 | 0.030 |
Why?
|
| Prosthesis Failure | 2 | 2010 | 130 | 0.030 |
Why?
|
| Artifacts | 1 | 1995 | 125 | 0.030 |
Why?
|
| Heart Failure | 3 | 2006 | 1179 | 0.030 |
Why?
|
| Body Surface Area | 1 | 1994 | 20 | 0.030 |
Why?
|
| Postoperative Period | 2 | 2011 | 238 | 0.030 |
Why?
|
| Death, Sudden | 1 | 1994 | 24 | 0.030 |
Why?
|
| Radiography | 1 | 1995 | 572 | 0.030 |
Why?
|
| Hemofiltration | 1 | 1993 | 7 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1994 | 351 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 1994 | 94 | 0.030 |
Why?
|
| Thrombosis | 2 | 2008 | 218 | 0.030 |
Why?
|
| Combined Modality Therapy | 3 | 1991 | 951 | 0.030 |
Why?
|
| Thrombelastography | 1 | 1993 | 19 | 0.030 |
Why?
|
| Infant, Premature, Diseases | 1 | 1994 | 85 | 0.030 |
Why?
|
| Chordae Tendineae | 1 | 1992 | 7 | 0.030 |
Why?
|
| Plasmapheresis | 1 | 1993 | 18 | 0.030 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 1992 | 9 | 0.030 |
Why?
|
| Monitoring, Intraoperative | 1 | 1993 | 53 | 0.030 |
Why?
|
| Surgical Flaps | 1 | 1994 | 120 | 0.030 |
Why?
|
| Platelet Transfusion | 1 | 1993 | 21 | 0.030 |
Why?
|
| Oximetry | 1 | 1992 | 29 | 0.030 |
Why?
|
| Automobile Driving | 1 | 1993 | 88 | 0.030 |
Why?
|
| Intensive Care Units | 2 | 2008 | 344 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 1995 | 1140 | 0.030 |
Why?
|
| Actuarial Analysis | 2 | 2003 | 23 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 1745 | 0.030 |
Why?
|
| Transposition of Great Vessels | 1 | 1992 | 51 | 0.030 |
Why?
|
| Contraindications | 1 | 2011 | 52 | 0.030 |
Why?
|
| Heart Arrest | 1 | 1992 | 113 | 0.020 |
Why?
|
| Endocarditis | 1 | 1991 | 14 | 0.020 |
Why?
|
| Lysine | 1 | 2011 | 96 | 0.020 |
Why?
|
| Exercise Test | 3 | 1989 | 242 | 0.020 |
Why?
|
| Laser Therapy | 1 | 1991 | 54 | 0.020 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 1990 | 34 | 0.020 |
Why?
|
| Respiratory Insufficiency | 1 | 2011 | 76 | 0.020 |
Why?
|
| Collagen | 1 | 1994 | 636 | 0.020 |
Why?
|
| Propensity Score | 1 | 2011 | 116 | 0.020 |
Why?
|
| Angiography | 1 | 2011 | 194 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 2 | 1993 | 219 | 0.020 |
Why?
|
| Electroencephalography | 1 | 1993 | 418 | 0.020 |
Why?
|
| Physical Exertion | 1 | 1990 | 75 | 0.020 |
Why?
|
| Tachycardia, Supraventricular | 1 | 1990 | 73 | 0.020 |
Why?
|
| Amiodarone | 1 | 1990 | 21 | 0.020 |
Why?
|
| Pneumonectomy | 2 | 1988 | 79 | 0.020 |
Why?
|
| Lidocaine | 1 | 1990 | 36 | 0.020 |
Why?
|
| Weight Gain | 1 | 1991 | 135 | 0.020 |
Why?
|
| Catheterization | 1 | 1991 | 209 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 1990 | 44 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2010 | 242 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 1990 | 106 | 0.020 |
Why?
|
| Probability | 1 | 2010 | 244 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 700 | 0.020 |
Why?
|
| Hematologic Tests | 2 | 2004 | 24 | 0.020 |
Why?
|
| Animals | 5 | 1997 | 20880 | 0.020 |
Why?
|
| Cause of Death | 2 | 2000 | 241 | 0.020 |
Why?
|
| Phlebitis | 1 | 1988 | 4 | 0.020 |
Why?
|
| Coronary Disease | 1 | 1990 | 358 | 0.020 |
Why?
|
| Equipment Safety | 1 | 2008 | 50 | 0.020 |
Why?
|
| Long-Term Care | 1 | 2008 | 53 | 0.020 |
Why?
|
| Patient Selection | 2 | 2006 | 592 | 0.020 |
Why?
|
| Chronic Disease | 3 | 1992 | 1329 | 0.020 |
Why?
|
| Office Visits | 1 | 1988 | 83 | 0.020 |
Why?
|
| Telephone | 1 | 1988 | 160 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 1988 | 369 | 0.020 |
Why?
|
| Pneumonia | 1 | 2008 | 110 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 1046 | 0.020 |
Why?
|
| Preoperative Care | 2 | 2006 | 275 | 0.020 |
Why?
|
| Operating Rooms | 1 | 1988 | 108 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 1988 | 219 | 0.020 |
Why?
|
| Pulmonary Artery | 2 | 2004 | 323 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 1988 | 168 | 0.020 |
Why?
|
| Blood Pressure | 3 | 2004 | 1449 | 0.020 |
Why?
|
| Adenocarcinoma | 2 | 1989 | 475 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2008 | 384 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 1989 | 467 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 742 | 0.020 |
Why?
|
| Comprehensive Health Care | 1 | 2006 | 26 | 0.020 |
Why?
|
| Aging | 1 | 1992 | 911 | 0.020 |
Why?
|
| Isotonic Solutions | 1 | 1985 | 25 | 0.020 |
Why?
|
| Hydroxyethyl Starch Derivatives | 1 | 1985 | 24 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2006 | 349 | 0.020 |
Why?
|
| Starch | 1 | 1985 | 18 | 0.020 |
Why?
|
| Albumins | 1 | 1985 | 72 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1985 | 166 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2006 | 392 | 0.020 |
Why?
|
| Spasm | 1 | 2004 | 18 | 0.020 |
Why?
|
| Program Development | 1 | 2006 | 240 | 0.020 |
Why?
|
| Injections | 1 | 2004 | 119 | 0.020 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2004 | 49 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2004 | 55 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 2004 | 57 | 0.010 |
Why?
|
| Electrolytes | 1 | 2004 | 47 | 0.010 |
Why?
|
| Contracture | 1 | 1984 | 15 | 0.010 |
Why?
|
| Disease Management | 1 | 2006 | 248 | 0.010 |
Why?
|
| beta Catenin | 1 | 2004 | 73 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2004 | 58 | 0.010 |
Why?
|
| Endocarditis, Bacterial | 1 | 1984 | 32 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1983 | 89 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 1985 | 383 | 0.010 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2003 | 4 | 0.010 |
Why?
|
| Brain | 1 | 1994 | 2176 | 0.010 |
Why?
|
| Therapeutic Irrigation | 1 | 1983 | 63 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 108 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2003 | 95 | 0.010 |
Why?
|
| Gene Amplification | 1 | 2003 | 71 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2006 | 621 | 0.010 |
Why?
|
| Neomycin | 1 | 1983 | 56 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2003 | 86 | 0.010 |
Why?
|
| Rabbits | 1 | 1983 | 509 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1990 | 2550 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 194 | 0.010 |
Why?
|
| Thermodilution | 2 | 1992 | 20 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2004 | 237 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2004 | 317 | 0.010 |
Why?
|
| Dogs | 1 | 1983 | 490 | 0.010 |
Why?
|
| Bronchiectasis | 1 | 1982 | 25 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 282 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 411 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 682 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 2324 | 0.010 |
Why?
|
| Erythrocyte Transfusion | 1 | 2001 | 72 | 0.010 |
Why?
|
| Thrombophlebitis | 1 | 1980 | 47 | 0.010 |
Why?
|
| Heart Injuries | 1 | 1980 | 25 | 0.010 |
Why?
|
| Popliteal Artery | 1 | 1980 | 40 | 0.010 |
Why?
|
| Angina Pectoris | 1 | 2000 | 61 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2003 | 444 | 0.010 |
Why?
|
| Heart Ventricles | 3 | 1990 | 738 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 1465 | 0.010 |
Why?
|
| Spleen | 1 | 1980 | 301 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2004 | 753 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 756 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2003 | 371 | 0.010 |
Why?
|
| Prognosis | 1 | 2004 | 2093 | 0.010 |
Why?
|
| Pancreatitis | 1 | 1980 | 279 | 0.010 |
Why?
|
| Stroke | 1 | 2011 | 2162 | 0.010 |
Why?
|
| Blood Volume | 1 | 1997 | 47 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1997 | 304 | 0.010 |
Why?
|
| Echoencephalography | 1 | 1994 | 10 | 0.010 |
Why?
|
| Syndrome | 1 | 1994 | 255 | 0.010 |
Why?
|
| Centrifugation | 1 | 1993 | 16 | 0.010 |
Why?
|
| Platelet Count | 1 | 1993 | 100 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 1994 | 109 | 0.010 |
Why?
|
| Fibrinogen | 1 | 1993 | 87 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1997 | 1738 | 0.010 |
Why?
|
| Hypotension | 1 | 1993 | 74 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 1993 | 91 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1997 | 2083 | 0.010 |
Why?
|
| Smoking | 1 | 2000 | 1449 | 0.010 |
Why?
|
| Emergencies | 1 | 1992 | 107 | 0.010 |
Why?
|
| Quality of Life | 1 | 2000 | 1515 | 0.010 |
Why?
|
| Pectoralis Muscles | 1 | 1991 | 12 | 0.010 |
Why?
|
| Methods | 1 | 1991 | 156 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1994 | 415 | 0.010 |
Why?
|
| Ventricular Function | 1 | 1990 | 93 | 0.010 |
Why?
|
| Biomedical Engineering | 1 | 1990 | 20 | 0.010 |
Why?
|
| Magnetics | 1 | 1990 | 52 | 0.010 |
Why?
|
| Rest | 1 | 1989 | 78 | 0.010 |
Why?
|
| Electric Countershock | 1 | 1990 | 130 | 0.010 |
Why?
|
| Rats | 1 | 1997 | 5300 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1990 | 567 | 0.010 |
Why?
|
| Methylprednisolone | 1 | 1988 | 99 | 0.000 |
Why?
|
| Carcinoma | 1 | 1989 | 215 | 0.000 |
Why?
|
| Brain Ischemia | 1 | 1993 | 665 | 0.000 |
Why?
|
| Age Factors | 1 | 1991 | 1860 | 0.000 |
Why?
|
| Costs and Cost Analysis | 1 | 1986 | 193 | 0.000 |
Why?
|
| Mitomycins | 1 | 1985 | 4 | 0.000 |
Why?
|
| Cobalt Radioisotopes | 1 | 1985 | 4 | 0.000 |
Why?
|
| Mitomycin | 1 | 1985 | 27 | 0.000 |
Why?
|
| Body Fluids | 1 | 1985 | 41 | 0.000 |
Why?
|
| Blood Coagulation Factors | 1 | 1985 | 44 | 0.000 |
Why?
|
| Colloids | 1 | 1985 | 43 | 0.000 |
Why?
|
| Radiotherapy Dosage | 1 | 1985 | 125 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1988 | 458 | 0.000 |
Why?
|
| Lymph Node Excision | 1 | 1985 | 91 | 0.000 |
Why?
|
| Esophagoscopy | 1 | 1985 | 72 | 0.000 |
Why?
|
| Fluorouracil | 1 | 1985 | 130 | 0.000 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 1985 | 82 | 0.000 |
Why?
|
| Esophagitis | 1 | 1985 | 45 | 0.000 |
Why?
|
| Airway Obstruction | 1 | 1985 | 49 | 0.000 |
Why?
|
| Random Allocation | 1 | 1985 | 442 | 0.000 |
Why?
|
| Abscess | 1 | 1984 | 37 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1985 | 799 | 0.000 |
Why?
|
| Myocardium | 1 | 1988 | 1204 | 0.000 |
Why?
|
| Cardiomyopathies | 1 | 1984 | 167 | 0.000 |
Why?
|
| Respiratory Function Tests | 1 | 1982 | 123 | 0.000 |
Why?
|
| Deglutition Disorders | 1 | 1985 | 297 | 0.000 |
Why?
|
| United States | 1 | 1993 | 7338 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1984 | 848 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1982 | 1026 | 0.000 |
Why?
|